Orientation of Pseudomonas aeruginosa ExsA monomers bound to promoter DNA and base-specific contacts with the PexoT promoter

Journal of Bacteriology

Volumn 194, Issue 10, 2012, Pages 2573-2585

  King, Jessica M ^a   Brutinel, Evan D ^a,c   Marsden, Anne E ^a   Schubot, Florian D ^b   Yahr, Timothy L ^a  

^a UNIVERSITY OF IOWA   (United States)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BACTERIAL PROTEIN; CYTOSINE; EXSA PROTEIN; GUANINE; MONOMER; UNCLASSIFIED DRUG;

ALPHA HELIX; ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA FOOTPRINTING; GENETIC SCREENING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN MOTIF; PROTEIN STRUCTURE; PSEUDOMONAS AERUGINOSA; SEQUENCE ANALYSIS;

ADP RIBOSE TRANSFERASES; AMINO ACID SEQUENCE; BACTERIAL PROTEINS; BASE SEQUENCE; BINDING SITES; DNA, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; GTPASE-ACTIVATING PROTEINS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PSEUDOMONAS AERUGINOSA; RECOMBINANT FUSION PROTEINS; TRANS-ACTIVATORS;

PSEUDOMONAS AERUGINOSA;

EID: 84861359963     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.00107-12     Document Type: Article

References (46)

1. Apodaca G, et al. 1995. Characterization of Pseudomonas aeruginosainduced MDCK cell injury: glycosylation-defective host cells are resistant to bacterial killing. Infect. Immun. 63:1541-1551.
2. Barbieri JT, Sun J. 2004. Pseudomonas aeruginosa ExoS and ExoT. Rev. Physiol. Biochem. Pharmacol. 152:79-92.
3. Becher A, Schweizer HP. 2000. Integration-proficient Pseudomonas aeruginosa vectors for isolation of single-copy chromosomal lacZ and lux gene fusions. Biotechniques 29:948-950, 952.
4. Bhende PM, Egan SM. 1999. Amino acid-DNA contacts by RhaS: an AraC family transcription activator. J. Bacteriol. 181:5185-5192.
5. Brunelle A, Schleif R. 1989. Determining residue-base interactions between AraC protein and araI DNA. J. Mol. Biol. 209:607-622.
6. Brutinel ED, Vakulskas CA, Brady KM, Yahr TL. 2008. Characterization of ExsA and of ExsA-dependent promoters required for expression of the Pseudomonas aeruginosa type III secretion system. Mol. Microbiol. 68:657-671.
7. Brutinel ED, Vakulskas CA, Yahr TL. 2010. ExsD inhibits expression of the Pseudomonas aeruginosa type III secretion system by disrupting ExsA self-association and DNA binding activity. J. Bacteriol. 192:1479-1486.
8. Brutinel ED, Vakulskas CA, Yahr TL. 2009. Functional domains of ExsA, the transcriptional activator of the Pseudomonas aeruginosa type III secretion system. J. Bacteriol. 191:3811-3821.
9. Brutinel ED, King JM, Marsden AE, Yahr TL. 2012. The distal ExsAbinding site in Pseudomonas aeruginosa type III secretion system promoters is the primary determinant for promoter-specific properties. J. Bacteriol. 194:2564-2572.
10. Dasgupta N, Lykken GL, Wolfgang MC, Yahr TL. 2004. A novel antianti-activator mechanism regulates expression of the Pseudomonas aeruginosa type III secretion system. Mol. Microbiol. 53:297-308.
11. Diaz MR, King JM, Yahr TL. 2011. Intrinsic and extrinsic regulation of type III secretion gene expression in Pseudomonas aeruginosa. Front. Microbiol. 2:89.
12. Dominguez-Cuevas P, Marin P, Marques S, Ramos JL. 2008. XylS-Pm promoter interactions through two helix-turn-helix motifs: identifying XylS residues important for DNA binding and activation. J. Mol. Biol. 375:59-69.
13. Ebright YW, Chen Y, Pendergrast PS, Ebright RH. 1992. Incorporation of an EDTA-metal complex at a rationally selected site within a protein: application to EDTA-iron DNA affinity cleaving with catabolite gene activator protein (CAP) and Cro. Biochemistry 31:10664-10670.
14. Egan SM. 2002. Growing repertoire of AraC/XylS activators. J. Bacteriol. 184:5529-5532.
15. Grainger DC, Belyaeva TA, Lee DJ, Hyde EI, Busby SJ. 2003. Binding of the Escherichia coli MelR protein to the melAB promoter: orientation of MelR subunits and investigation of MelR-DNA contacts. Mol. Microbiol. 48:335-348.
16. Grier MC, et al. 2010. N-Hydroxybenzimidazole inhibitors of ExsA MAR transcription factor in Pseudomonas aeruginosa: in vitro anti-virulence activity and metabolic stability. Bioorg. Med. Chem. Lett. 20:3380-3383.
17. Hauser AR. 2009. The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat. Rev. Microbiol. 7:654-665.
18. Hayes JJ, Tullius TD. 1989. The missing nucleoside experiment: a new technique to study recognition ofDNAby protein. Biochemistry 28:9521-9527.
19. Hendrickson W, Schleif R. 1985. A dimer of AraC protein contacts three adjacent major groove regions of the araI DNA site. Proc. Natl. Acad. Sci. U. S. A. 82:3129-3133.
20. Hoang TT, Kutchma AJ, Becher A, Schweizer HP. 2000. Integrationproficient plasmids for Pseudomonas aeruginosa: site-specific integration and use for engineering of reporter and expression strains. Plasmid 43:59-72.
21. Holder IA, Neely AN, Frank DW. 2001. PcrV immunization enhances survival of burned Pseudomonas aeruginosa-infected mice. Infect. Immun. 69:5908-5910.
22. Holder IA, Neely AN, Frank DW. 2001. Type III secretion/intoxication system important in virulence of Pseudomonas aeruginosa infections in burns. Burns 27:129-130.
23. Hovey AK, Frank DW. 1995. Analyses of the DNA-binding and transcriptional activation properties of ExsA, the transcriptional activator of the Pseudomonas aeruginosa exoenzyme S regulon. J. Bacteriol. 177:4427-4436.
24. Kurahashi K, et al. 1999. Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia. J. Clin. Invest. 104:743-750.
25. Kwon HJ, Bennik MH, Demple B, Ellenberger T. 2000. Crystal structure of the Escherichia coli Rob transcription factor in complex with DNA. Nat. Struct. Biol. 7:424-430.
26. Lee VT, et al. 2007. Pseudolipasin A is a specific inhibitor for phospholipase A2 activity of Pseudomonas aeruginosa cytotoxin ExoU. Infect. Immun. 75:1089-1098.
27. Martin RG, Rosner JL. 2001. The AraC transcriptional activators. Curr. Opin. Microbiol. 4:132-137.
28. McCaw ML, Lykken GL, Singh PK, Yahr TL. 2002. ExsD is a negative regulator of the Pseudomonas aeruginosa type III secretion regulon. Mol. Microbiol. 46:1123-1133.
29. Newman JR, Fuqua C. 1999. Broad-host-range expression vectors that carry the L-arabinose-inducible Escherichia coli araBAD promoter and the araC regulator. Gene 227:197-203.
30. Niland P, Huhne R, Muller-Hill B. 1996. How AraC interacts specifically with its target DNAs. J. Mol. Biol. 264:667-674.
31. Rana TM, Meares CF. 1991. Transfer of oxygen from an artificial protease to peptide carbon during proteolysis. Proc. Natl. Acad. Sci. U. S. A. 88: 10578-10582.
32. Rhee S, Martin RG, Rosner JL, Davies DR. 1998. A novel DNA-binding motif in MarA: the first structure for an AraC family transcriptional activator. Proc. Natl. Acad. Sci. U. S. A. 95:10413-10418.
33. Richards MJ, Edwards JR, Culver DH, Gaynes RP. 2000. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect. Control Hosp. Epidemiol. 21:510-515.
34. Richards MJ, Edwards JR, Culver DH, Gaynes RP. 1999. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit. Care Med. 27:887-892.
35. Rietsch A, Vallet-Gely I, Dove SL, Mekalanos JJ. 2005. ExsE, a secreted regulator of type III secretion genes in Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U. S. A. 102:8006-8011.
36. Roy-Burman A, et al. 2001. Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J. Infect. Dis. 183:1767-1774.
37. Sato H, Frank DW. 2004. ExoU is a potent intracellular phospholipase. Mol. Microbiol. 53:1279-1290.
38. Sawa T, et al. 1999. Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury. Nat. Med. 5:392-398.
39. Soisson SM, MacDougall-Shackleton B, Schleif R, Wolberger C. 1997. Structural basis for ligand-regulated oligomerization of AraC. Science 276:421-425.
40. Thibault J, Faudry E, Ebel C, Attree I, Elsen S. 2009. Anti-activator ExsD forms a 1:1 complex with ExsA to inhibit transcription of type III secretion operons. J. Biol. Chem. 284:15762-15770.
41. Urbanowski ML, Brutinel ED, Yahr TL. 2007. Translocation of ExsE into Chinese hamster ovary cells is required for transcriptional induction of the Pseudomonas aeruginosa type III secretion system. Infect. Immun. 75:4432-4439.
42. Urbanowski ML, Lykken GL, Yahr TL. 2005. A secreted regulatory protein couples transcription to the secretory activity of the Pseudomonas aeruginosa type III secretion system. Proc. Natl. Acad. Sci. U. S. A. 102: 9930-9935.
43. Vogel HJ, Bonner DM. 1956. Acetylornithinase of Escherichia coli: partial purification and some properties. J. Biol. Chem. 218:97-106.
44. Withey JH, DiRita VJ. 2006. The toxbox: specific DNA sequence requirements for activation of Vibrio cholerae virulence genes by ToxT. Mol. Microbiol. 59:1779-1789.
45. Yahr TL, Wolfgang MC. 2006. Transcriptional regulation of the Pseudomonas aeruginosa type III secretion system. Mol. Microbiol. 62:631-640.
46. Zheng Z, et al. 2007. Biochemical characterization of a regulatory cascade controlling transcription of the Pseudomonas aeruginosa type III secretion system. J. Biol. Chem. 282:6136-6142.